Literature DB >> 12192619

Novel polymorphisms in the somatostatin receptor 5 (SSTR5) gene associated with bipolar affective disorder.

M Nyegaard1, A D Børglum, T G Bruun, D A Collier, C Russ, O Mors, H Ewald, T A Kruse.   

Abstract

The somatostatin receptor 5 (SSTR5) gene is a candidate gene for bipolar affective disorder (BPAD) as well as for other neuropsychiatric disorders. The gene is positioned on chromosome 16p13.3, a region that has been implicated by a few linkage studies to potentially harbor a disease susceptibility gene for BPAD. Recent evidence shows that the dopamine D2 receptor (DRD2) and SSTR5 interact physically to form heterodimers with enhanced functional activity. Brain D2 dopamine receptors are one of the major targets of neuroleptic treatments in psychiatric disorders. In this study we systematically screened the promoter and coding region of the SSTR5 gene for genetic variation that could contribute to the development of neuropsychiatric disorders. Eleven novel single nucleotide polymorphisms (SNPs) were identified including four missense SNPs, Leu48Met, Ala52Val, Pro109Ser and Pro335Leu. We carried out an association study of BPAD using 80 Danish cases and 144 control subjects, and replication analysis using 55 British cases and 88 control subjects. For the Danish population, association was suggested between silent SNP G573A and BPAD (P = 0.008). For the British population we found association to BPAD with missense mutation Leu48Met (P = 0.003) and missense mutation Pro335Leu (P = 0.004). The statistical significance of the association was, however, greatly reduced after correcting for multiple testing. When combining genotypes from Leu48Met and Pro335Leu into haplotypes, association to BPAD was found in the British population (P = 0.0007). This haplotype association was not replicated in the Danish population. Our results may indicate that the SSTR5 gene is involved in the etiology of BPAD or may exist in linkage disequilibrium with a susceptibility gene close to SSTR5. However, given the marginal statistical significance and the potential for false-positive results in association studies with candidate genes, further studies are needed to clarify this hypothesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12192619     DOI: 10.1038/sj.mp.4001049

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  11 in total

Review 1.  International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.

Authors:  Thomas Günther; Giovanni Tulipano; Pascal Dournaud; Corinne Bousquet; Zsolt Csaba; Hans-Jürgen Kreienkamp; Amelie Lupp; Márta Korbonits; Justo P Castaño; Hans-Jürgen Wester; Michael Culler; Shlomo Melmed; Stefan Schulz
Journal:  Pharmacol Rev       Date:  2018-10       Impact factor: 25.468

2.  Somatotroph pituitary adenoma with acromegaly and autosomal dominant polycystic kidney disease: SSTR5 polymorphism and PKD1 mutation.

Authors:  Luis V Syro; Jamie L Sundsbak; Bernd W Scheithauer; Rodrigo A Toledo; Mauricio Camargo; Christina M Heyer; Tomoko Sekiya; Humberto Uribe; Jorge I Escobar; Martin Vasquez; Fabio Rotondo; Sergio P A Toledo; Kalman Kovacs; Eva Horvath; Dusica Babovic-Vuksanovic; Peter C Harris
Journal:  Pituitary       Date:  2012-09       Impact factor: 4.107

3.  Loss of heterozygosity at the SS receptor type 5 locus in human GH- and TSH-secreting pituitary adenomas.

Authors:  M Filopanti; E Ballarè; A G Lania; S Bondioni; U Verga; M Locatelli; L M Zavanone; M Losa; S Gelmini; A Peri; C Orlando; P Beck-Peccoz; A Spada
Journal:  J Endocrinol Invest       Date:  2004-11       Impact factor: 4.256

4.  SSTR5 P335L monoclonal antibody differentiates pancreatic neuroendocrine neuroplasms with different SSTR5 genotypes.

Authors:  Guisheng Zhou; Marie-Claude Gingras; Shi-He Liu; Robbi Sanchez; Dean Edwards; David Dawson; Kurt Christensen; Giovanni Paganelli; Richard Gibbs; William Fisher; Francis C Brunicardi
Journal:  Surgery       Date:  2011-12       Impact factor: 3.982

5.  The hypofunctional effect of P335L single nucleotide polymorphism on SSTR5 function.

Authors:  Guisheng Zhou; Marie-Claude Gingras; Shi-He Liu; Donghui Li; Zhijun Li; Robbi L Catania; Kelly M Stehling; Min Li; Giovanni Paganelli; Richard A Gibbs; Francesco J Demayo; William E Fisher; F Charles Brunicardi
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

6.  Analysis of transmission of novel polymorphisms in the somatostatin receptor 5 (SSTR5) gene in patients with autism.

Authors:  Marlene B Lauritsen; Mette Nyegaard; Catalina Betancur; Catherine Colineaux; Trine L Josiassen; Torben A Kruse; Marion Leboyer; Henrik Ewald
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2003-08-15       Impact factor: 3.568

Review 7.  Molecular genetics of human growth hormone, insulin-like growth factors and their pathways in common disease.

Authors:  Santiago Rodriguez; Tom R Gaunt; Ian N M Day
Journal:  Hum Genet       Date:  2007-05-30       Impact factor: 4.132

8.  Decreased Numbers of Somatostatin-Expressing Neurons in the Amygdala of Subjects With Bipolar Disorder or Schizophrenia: Relationship to Circadian Rhythms.

Authors:  Harry Pantazopoulos; Jason T Wiseman; Matej Markota; Lucy Ehrenfeld; Sabina Berretta
Journal:  Biol Psychiatry       Date:  2016-04-16       Impact factor: 13.382

9.  Identification of somatostatin receptor type 5 gene polymorphisms associated with acromegaly.

Authors:  Darja Ciganoka; Inga Balcere; Ivo Kapa; Raitis Peculis; Andra Valtere; Liene Nikitina-Zake; Ieva Lase; Helgi B Schiöth; Valdis Pirags; Janis Klovins
Journal:  Eur J Endocrinol       Date:  2011-08-02       Impact factor: 6.664

Review 10.  Reduced brain somatostatin in mood disorders: a common pathophysiological substrate and drug target?

Authors:  Li-Chun Lin; Etienne Sibille
Journal:  Front Pharmacol       Date:  2013-09-09       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.